Along with double-downgrading the stock, Citi cut Biocon’s target price to Rs 360 per share from Rs 430 per share. The latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback